News Release

INEOS Styrolution continues innovating for the healthcare industry


Frankfurt, Germany

  • New styrenic solutions for the healthcare industry
  • Visit INEOS Styrolution at MD&M West in Anaheim, California (Feb 6-8, 2018), booth 611
  • Visit INEOS Styrolution at Pharmapack in Paris, France (Feb 7-8, 2018), hall 7.1, booth L14

INEOS Styrolution, the global leader in styrenics, will present new innovative styrenic solutions for the healthcare industry at MD&M West 2018 in Anaheim, California (Anaheim Convention Center) and at Pharmapack 2018 in Paris (Paris Expo, Porte de Versailles).

Customers looking for new materials for their latest healthcare application designs will have the opportunity to meet experts from INEOS Styrolution in early February at Pharmapack 2018 and at MD&M West 2018. All healthcare application developers are invited to share their material needs, discover the properties of INEOS Styrolution’s latest styrenic solutions and explore opportunities to cooperate.

INEOS Styrolution’s portfolio for the healthcare industry includes

- a wide range of SBC solutions including K-Resin® SBC and Styrolux® SBC. They are a perfect fit for healthcare applications like drip chambers, labware and drainage containers.

- Lustran® and Novodur® HD ABS – attractive materials for many leading medical device manufacturers due to their good chemical resistance, flowability, surface appearance and suitability for common sterilization methods. Both materials are the inhaler housing resins of choice.

- transparent specialty solutions Clearblend® and Zylar® that excel with high clarity, exceptional performance in drop tests (Zylar 670), exceptional toughness (Clearblend 165, Zylar 960) and other properties relevant in the healthcare industry.

- Terlux® HD transparent specialty solutions offering excellent transparency and good resistance to chemicals.

- special purpose solutions like Novodur® HD M203FC G3 – the first glass fiber filled polymer grade which is certified against the relevant parts of the biocompatibility standard ISO 10993.

INEOS Styrolution provides three dedicated healthcare service packages addressing all aspects relevant to healthcare device manufacturers including regulatory compliance:

- Full Service HD Package (Risk Class 1 & 2)

  • Up to 36 months notification of change with signed long term supply contract
  • Locked formulations as defined in the drug master file filed with the FDA
  • Food contact statements, USP class VI, ISO 10993, DMF
  • Security of supply, long-term and global availability
  • Increased technical support (color & application development, design support)

- Essential HD Package (Risk Class 1 & 2)

  • Up to 12 months notification of change with signed long term supply contract
  • Food contact statements, USP class VI, ISO 10993, DMF

- Standard Food Contact (Risk Class 1)

  • FDA and EU food contact statements available
“We invite healthcare application providers to stop by, explore the properties of our materials and challenge our experts,” comments Alexander Silvestre, Global Director – Healthcare. “Let’s work together to make your ideas become reality.”